EP 4117676 A1 20230118 - USE OF A NICOTINAMIDE MONONUCLEOTIDE OR SOME OF ITS DERIVATIVES FOR PREVENTING AND/OR TREATING DORSAL PAIN, AND CORRESPONDING COMPOSITIONS
Title (en)
USE OF A NICOTINAMIDE MONONUCLEOTIDE OR SOME OF ITS DERIVATIVES FOR PREVENTING AND/OR TREATING DORSAL PAIN, AND CORRESPONDING COMPOSITIONS
Title (de)
VERWENDUNG EINES NIKOTINAMIDMONONUKLEOTIDS ODER MEHRERER SEINER DERIVATE ZUR VORBEUGUNG UND/ODER BEHANDLUNG VON DORSALSCHMERZEN UND ENTSPRECHENDE ZUSAMMENSETZUNGEN
Title (fr)
UTILISATION DE NICOTINAMIDE MONONUCLÉOTIDE OU DE CERTAINS DE SES DÉRIVÉS POUR LA PREVENTION ET/OU LE TRAITEMENT D'UNE DOULEUR DORSALE, ET COMPOSITIONS CORRESPONDANTES
Publication
Application
Priority
- FR 2002475 A 20200312
- EP 2021056318 W 20210312
Abstract (en)
[origin: CA3175088A1] The invention relates to a nicotinamide mononucleotide, to one of the pharmaceutically acceptable derivatives thereof or to one of the pharmaceutically acceptable salts thereof, for the use thereof in the prevention and/or treatment of dorsal pain, such as lower back pain, back pain or neck pain, preferably a chronic lower back pain, as well as to compositions comprising same.
IPC 8 full level
A61K 31/706 (2006.01); A61K 9/00 (2006.01); A61P 29/00 (2006.01)
CPC (source: EP US)
A61K 9/0014 (2013.01 - EP US); A61K 9/107 (2013.01 - US); A61K 31/706 (2013.01 - EP US); A61K 31/7084 (2013.01 - US); A61K 47/10 (2013.01 - US); A61K 47/14 (2013.01 - US); A61K 47/22 (2013.01 - US); A61K 47/44 (2013.01 - US); A61P 29/00 (2018.01 - EP US)
C-Set (source: EP)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
FR 3108031 A1 20210917; FR 3108031 B1 20240216; AU 2021236358 A1 20221006; CA 3175088 A1 20210916; CN 115484962 A 20221216; EP 4117676 A1 20230118; JP 2023518206 A 20230428; US 2023172959 A1 20230608; WO 2021180915 A1 20210916
DOCDB simple family (application)
FR 2002475 A 20200312; AU 2021236358 A 20210312; CA 3175088 A 20210312; CN 202180032248 A 20210312; EP 2021056318 W 20210312; EP 21710972 A 20210312; JP 2022555073 A 20210312; US 202117910581 A 20210312